AF
CVM icon

Amalgamated Financial’s CEL-SCI Corp CVM Stock Holding History

Amalgamated Financial’s Portfolio CVM Stock Details CVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$23K Buy
+191
New +$31.1K ﹤0.01% 2695

Other funds holding CVM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amalgamated Financial's CVM Position: Q1 2022 in Review

Amalgamated Financial opened a new position in CEL-SCI Corp (CVM) in Q1 2022: 191 shares worth $23K. The stake represents ﹤0.01% of the portfolio and ranks #2695 among its holdings.

110 funds tracked by Wall St. Rank hold CVM as of Q1 2022.

  • Amalgamated Financial held 191 shares of CEL-SCI Corp worth $23K as of Q1 2022.
  • CEL-SCI Corp was a new Amalgamated Financial position in Q1 2022.
  • CEL-SCI Corp made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2695 holding.
  • 110 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.